retatrutide safety clinical trial Efficacy and of retatrutide, a GIP, GLP-1, and glucagon receptor agonist, in people with type 2 diabetes and inadequate glycaemic control with diet and exercise (TRANSCEND-T2D-1): a double-blind, randomised, phase 3 🚨 “Retatrutide” isn't approved or

[26] Terns Pharmaceuticals

Inhibiting TRPV1 has proven effective in mitigating pain in diverse neuropathic pain models, thereby garnering interest from numerous pharmaceutical companies 22,23

Our Sleep and Recovery in Longevity Medicine page and article on Sleep, Hormones, Recovery, and Longevity explain why sleep is not optional biology

Bariatric Surgery: If youre seeking a long-lasting solution and are prepared for the commitment, surgery could be the answer

A Conversation Worth Having GLP-1 receptor agonists represent a genuine step change in the treatment of obesity

But rapid weight changes can tax your immune function